Suppr超能文献

淋巴母细胞摄取和降解鞘磷脂的不同途径以及中性鞘磷脂酶的潜在参与

Different pathways of uptake and degradation of sphingomyelin by lymphoblastoid cells and the potential participation of the neutral sphingomyelinase.

作者信息

Levade T, Gatt S, Maret A, Salvayre R

机构信息

Laboratoire de Biochimie, C.H.U. Rangueil, Toulouse Cédex, France.

出版信息

J Biol Chem. 1991 Jul 25;266(21):13519-29.

PMID:1649823
Abstract

The metabolism of sphingomyelin (SPM) was investigated in Epstein-Barr virus-transformed lymphoid cell lines from normal individuals and from patients with Niemann-Pick disease Type A (deficient in the acid, lysosomal sphingomyelinase) and familial hypercholesterolemia (lacking the low density lipoprotein receptor). Cells were incubated with the following radioactive or fluorescent SPMs: [choline-methyl-14C] SPM, [oleoyl-3H]SPM, pyrene-propenoyl-SPM (P3:1-SPM), pyrene-butanoyl-SPM (P4-SPM), pyrene-dodecanoyl-SPM (P12-SPM), and pyrene-sulfonylamino-undecanoyl-SPM (PSA11-SPM). Several pathways of uptake and subsequent metabolism of SPM in the lymphoblastoid cells were identified. [choline-methyl-14C]SPM and the P12-analog, administered to the cells in the presence of lipoproteins, were taken up through the apoB/E receptor-dependent pathway of endocytosis and degraded solely by the lysosomal sphingomyelinase. Under similar conditions, the other sphingomyelins, i.e. [oleoyl-3H]SPM, P3:1-SPM, P4-SPM, and PSA11-SPM, were taken up by a low density lipoprotein receptor-independent pathway and degraded mostly by a nonlysosomal sphingomyelinase which also catalyzed their hydrolysis in Niemann-Pick cells. In the absence of serum, all sphingomyelins were taken up by an apoB/E receptor-independent pathway and hydrolyzed by a nonlysosomal sphingomyelinase. Indeed, in vitro assays demonstrated the presence, in lymphoblastoid cells, of the neutral magnesium-activated sphingomyelinase, which was also fully active in the Niemann-Pick cells. In conclusion, our observations are consistent with: (i) the existence in lymphoblastoid cells of several pathways for the uptake and subsequent utilization of SPM; (ii) a major role of lipoproteins for the metabolic routing of the SPM; and (iii) the effect of the structure of the fatty acyl residue of SPM on its possible association with lipoproteins and/or cell membranes.

摘要

研究了来自正常个体、A型尼曼-匹克病患者(酸性溶酶体鞘磷脂酶缺乏)和家族性高胆固醇血症患者(低密度脂蛋白受体缺乏)的爱泼斯坦-巴尔病毒转化淋巴母细胞系中鞘磷脂(SPM)的代谢。将细胞与以下放射性或荧光性鞘磷脂一起孵育:[胆碱-甲基-¹⁴C]鞘磷脂、[油酰基-³H]鞘磷脂、芘丙烯酰基鞘磷脂(P3:1-SPM)、芘丁酰基鞘磷脂(P4-SPM)、芘十二烷酰基鞘磷脂(P12-SPM)和芘磺酰氨基十一烷酰基鞘磷脂(PSA11-SPM)。确定了淋巴母细胞中鞘磷脂摄取及后续代谢的几种途径。在脂蛋白存在的情况下给予细胞的[胆碱-甲基-¹⁴C]鞘磷脂和P12类似物,通过载脂蛋白B/E受体依赖性内吞途径被摄取,并仅由溶酶体鞘磷脂酶降解。在类似条件下,其他鞘磷脂,即[油酰基-³H]鞘磷脂、P3:1-SPM、P4-SPM和PSA11-SPM,通过低密度脂蛋白受体非依赖性途径被摄取,并且大部分由非溶酶体鞘磷脂酶降解,该酶也催化它们在尼曼-匹克细胞中的水解。在无血清的情况下,所有鞘磷脂都通过载脂蛋白B/E受体非依赖性途径被摄取,并由非溶酶体鞘磷脂酶水解。实际上,体外试验证明淋巴母细胞中存在中性镁激活的鞘磷脂酶,其在尼曼-匹克细胞中也完全有活性。总之,我们的观察结果与以下情况一致:(i)淋巴母细胞中存在几种鞘磷脂摄取及后续利用的途径;(ii)脂蛋白在鞘磷脂代谢途径中起主要作用;(iii)鞘磷脂脂肪酰基残基的结构对其与脂蛋白和/或细胞膜可能的结合的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验